Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate AVITA Medical Inc before investing.

In this article, we go over a few key elements for understanding AVITA Medical Inc’s stock price such as:

• AVITA Medical Inc’s current stock price and volume
• Why AVITA Medical Inc’s stock price changed recently
• Upgrades and downgrades for RCEL from analysts
• RCEL’s stock price momentum as measured by its relative strength

About AVITA Medical Inc (RCEL)

Before we jump into AVITA Medical Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.

Want to learn more about AVITA Medical Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about AVITA Medical Inc.

AVITA Medical Inc’s Stock Price as of Market Close

As of May 28, 2024, 4:00 PM, CST, AVITA Medical Inc’s stock price was $8.63.

AVITA Medical Inc is up 6.54% from its previous closing price of $8.10.

During the last market session, AVITA Medical Inc’s stock traded between $8.04 and $8.39. Currently, there are 25.64 million shares of AVITA Medical Inc stock available for purchase.

Unfortunately, AVITA Medical Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

AVITA Medical Inc Stock Price History

AVITA Medical Inc’s (RCEL) price is currently up 2.74% so far this month.

During the month of May, AVITA Medical Inc’s stock price has reached a high of $9.64 and a low of $7.51.

Over the last year, AVITA Medical Inc has hit prices as high as $21.70 and as low as $7.51. Year to date, AVITA Medical Inc’s stock is up 30.76%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused AVITA Medical Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 24, 2024, there were 5 analysts who downgraded AVITA Medical Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate AVITA Medical Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on AVITA Medical Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

AVITA Medical Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about AVITA Medical Inc (RCEL) by visiting AAII Stock Evaluator.

Relative Price Strength of AVITA Medical Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 24, 2024, AVITA Medical Inc has a weighted four-quarter relative price strength of -11.34%, which translates to a Momentum Score of 29 and is considered to be Weak.

Want to learn more about how AVITA Medical Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

AVITA Medical Inc Stock Price: Bottom Line

As of May 28, 2024, AVITA Medical Inc’s stock price is $8.63, which is up 6.54% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like AVITA Medical Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.